Study on Sintilimab in Stage IV High Risk Neuroblastoma

NCT04412408 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Stage IV High Risk Neuroblastoma

Interventions

DRUG: Sintilimab

Sponsor

Shanghai Children's Medical Center